Difference between revisions of "Scientific Articles on Psychedelics"
From DMT-Nexus Wiki
TheTraveler (Talk | contribs) (→Peyote) |
Endlessness (Talk | contribs) (→Other) |
||
(13 intermediate revisions by one user not shown) | |||
Line 1: | Line 1: | ||
− | {{ShowInfo|[[Image:Error.png]]|'''Note:'''|This page is a work in progress -- its content throughout is not yet complete.}} | + | {{ShowInfo|[[Image:Error.png]]|'''Note:'''|This page is a work in progress -- its content throughout is not yet complete.}}<br /> |
− | + | ||
− | + | ||
==Ayahuasca== | ==Ayahuasca== | ||
{{FileReference | {{FileReference | ||
Line 104: | Line 102: | ||
| | | | ||
}} | }} | ||
+ | |||
==DMT== | ==DMT== | ||
Line 127: | Line 126: | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media:DMT psychopharmacology.pdf|DMT psychopharmacology]] | |[[Media:DMT psychopharmacology.pdf|DMT psychopharmacology]] | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
| | | | ||
}} | }} | ||
+ | |||
==Ibogaine== | ==Ibogaine== | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:fatalities after ibogaine use.pdf|Fatalities after ibogaine use]] |
| | | | ||
|0px | |0px | ||
Line 145: | Line 139: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:ibogaine and cocaine abuse.pdf|Ibogaine and cocaine abuse]] |
| | | | ||
|0px | |0px | ||
Line 151: | Line 145: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:ibogaine and facilitation of memory retrieval.pdf|Ibogaine and facilitation of memory retrieval]] |
| | | | ||
|0px | |0px | ||
Line 157: | Line 151: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:Ibogaine mechanisms of anti addiction.pdf|Ibogaine mechanisms of anti addiction]] |
| | | | ||
|0px | |0px | ||
Line 163: | Line 157: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:ibogaine safety and efficacy.pdf|Ibogaine safety and efficacy]] |
| | | | ||
− | |||
}} | }} | ||
− | |||
− | |||
− | |||
− | |||
− | |||
==LSD== | ==LSD== | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:long term effects of lsd.pdf|Long term effects of LSD]] |
| | | | ||
|0px | |0px | ||
Line 183: | Line 171: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:therapy with lsd.pdf|Therapy with LSD]] |
| | | | ||
}} | }} | ||
− | |||
− | |||
==Peyote== | ==Peyote== | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:A STUDY ON MESCALINE IN HUMAN SUBJECTS.pdf|A Study on mescaline in human subjects]] |
| | | | ||
|0px | |0px | ||
Line 199: | Line 185: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:peyote long term psychological cognitive effects.pdf|Peyote long term psychological cognitive effects]] |
| | | | ||
|0px | |0px | ||
Line 205: | Line 191: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
− | |[[Media: | + | |[[Media:prehistoric peyote use.pdf|Prehistoric peyote use]] |
| | | | ||
}} | }} | ||
− | + | ||
− | + | ||
− | + | ||
==Psilocybin== | ==Psilocybin== | ||
− | + | {{FileReference | |
− | [ | + | |[[Image:Page_white_acrobat.png]] |
− | [ | + | |[[Media:cluster headache lsd psilocybin.pdf|Cluster headache lsd psilocybin]] |
− | [ | + | | |
− | [ | + | |0px |
− | [ | + | }} |
− | [ | + | {{FileReference |
− | [ | + | |[[Image:Page_white_acrobat.png]] |
+ | |[[Media:effects of psilocybin on humans.pdf|Effects of psilocybin on humans]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:effects of psilocybin on perception of time.pdf|Effects of psilocybin on perception of time]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:psilocybin and mystical experiences.pdf|Psilocybin and mystical experiences]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:Psilocybin and OCD.pdf|Psilocybin and OCD]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:psilocybin investigator brochure.pdf|Psilocybin investigator brochure]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:psilocybin, attention and working memory.pdf|Psilocybin, attention and working memory]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:psychedelic mushrooms in buddhist tradition.pdf|Psychedelic mushrooms in buddhist tradition]] | ||
+ | | | ||
+ | }} | ||
==Salvia Divinorum== | ==Salvia Divinorum== | ||
− | + | {{FileReference | |
− | [ | + | |[[Image:Page_white_acrobat.png]] |
+ | |[[Media:salvia divinorum pattern of use.pdf|Salvia divinorum pattern of use]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:Salv_A_PNAS.pdf|Salv_A_PNAS]] | ||
+ | | | ||
+ | }} | ||
==Other== | ==Other== | ||
− | + | {{FileReference | |
− | [ | + | |[[Image:Page_white_acrobat.png]] |
− | [ | + | |[[Media:Jf00077a037.pdf|Alkaloidal insect antifeedants from Virola calophylla]] |
− | [ | + | |Howard Miles, Ana Maria Ly, Shirley A. Randle, Paul A. Hedin, Marcus L. Burks Warb Journal of agricultural and food chemistry September 1987 Volume 35, Issue 5 D pp 794–797 |
− | [ | + | |0px |
− | [ | + | }} |
− | [ | + | {{FileReference |
− | [ | + | |[[Image:Page_white_acrobat.png]] |
− | [ | + | |[[Media:bufo alvarius - a potent hallucinogen.pdf|Bufo alvarius - a potent hallucinogen]] |
− | [ | + | | |
− | [ | + | |0px |
− | [ | + | }} |
− | [ | + | {{FileReference |
− | [ | + | |[[Image:Page_white_acrobat.png]] |
− | [ | + | |[[Media:entheogens and education potential.pdf|Entheogens and education potential]] |
− | [ | + | | |
− | [ | + | |0px |
− | [ | + | }} |
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:hallucinogens and redemption.pdf|Hallucinogens and redemption]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:HPPD - flashbacks.pdf|HPPD - flashbacks]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:JPharmBioAn-41-3-872.pdf|JPharmBioAn-41-3-872]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:Mining_Recepterome_Review_JBC.pdf|Mining_Recepterome_Review_JBC]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:natural hallucinogens growing in USA.pdf|Natural hallucinogens growing in USA]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:Nichols - Hallucinogens.pdf|Nichols - Hallucinogens]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:pharmañopo - Yopo pharmacology.pdf|Pharmañopo - Yopo pharmacology]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:pharmepena - epena pharmacology.pdf|Pharmepena - epena pharmacology]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:Proposed Mechanism for Dreams and Sleep.pdf|Proposed Mechanism for Dreams and Sleep]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:psychedelic adverse effects.pdf|Psychedelic adverse effects]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:Psychointegrators multidisciplinary approach.pdf|Psychointegrators multidisciplinary approach]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:Psychopharmacology of hallucinogens.pdf|Psychopharmacology of hallucinogens]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:psychosis and hallucinogens consciousness model.pdf|Psychosis and hallucinogens consciousness model]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:reducing drug problems with set and setting.pdf|Reducing drug problems with set and setting]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:serotonin and hallucinogens.pdf|Serotonin and hallucinogens]] | ||
+ | | | ||
+ | |0px | ||
+ | }} | ||
+ | {{FileReference | ||
+ | |[[Image:Page_white_acrobat.png]] | ||
+ | |[[Media:study of Values of psychedelic users.pdf|Study of Values of psychedelic users]] | ||
+ | | | ||
+ | }} | ||
[[Category:Supplementary Reference]] | [[Category:Supplementary Reference]] |
Latest revision as of 11:43, 24 October 2011
Note: | This page is a work in progress -- its content throughout is not yet complete. |
Ayahuasca
Ayahuasca and SSRI Interactions | Callaway, J.T., C.S. Grob. (October-December 1998). Journal of Psychoactive Drugs. pp. 367-369. |
Ayahuasca Adolescents ritual use | Doering-Silveira et al. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2). pp. 141-144. |
ayahuasca first time psychological after effects | Hoffman et al. (Spring 2001). Multidisciplinary Association for Psychedelic Studies. pp. 25-30. |
Ayahuasca and human destiny | McKenna, Dennis J. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2) pp. 231-234. |
Another Ayahuasca EEG study | Riba et al. (2002). British Journal of Clinical Pharmacology. Vol. 53. Blackwell Science Ltd. pp. 617-628. |
Ayahuasca in adolescence psychiatric evaluation |
ayahuasca in cross cultural perspective |
Ayahuasca neuroimaging |
Bringing Ayahuasca to clinical laboratory |
Effects of ayahuasca on panic and anxiety.pdf |
Globalization of ayahuasca |
Human pharmacology of ayahuasca |
Pharmacokinetics of hoasca in healthy humans |
Risk assessment of ritual ayahuasca use |
Thesis - Ayahuascapharmacology part1 |
Thesis - ayahuascapharmacology part2 |
Various alkaloid profiles in aya decoction |
DMT
DMT and BCarbolines in human plasma after dose |
DMT endogenous anxiolytic role |
DMT in psychiatric patients |
DMT psychopharmacology |
Ibogaine
Fatalities after ibogaine use |
Ibogaine and cocaine abuse |
Ibogaine and facilitation of memory retrieval |
Ibogaine mechanisms of anti addiction |
Ibogaine safety and efficacy |
LSD
Long term effects of LSD |
Therapy with LSD |
Peyote
A Study on mescaline in human subjects |
Peyote long term psychological cognitive effects |
Prehistoric peyote use |
Psilocybin
Cluster headache lsd psilocybin |
Effects of psilocybin on humans |
Effects of psilocybin on perception of time |
Psilocybin and mystical experiences |
Psilocybin and OCD |
Psilocybin investigator brochure |
Psilocybin, attention and working memory |
Psychedelic mushrooms in buddhist tradition |
Salvia Divinorum
Salvia divinorum pattern of use |
Salv_A_PNAS |
Other
Alkaloidal insect antifeedants from Virola calophylla | Howard Miles, Ana Maria Ly, Shirley A. Randle, Paul A. Hedin, Marcus L. Burks Warb Journal of agricultural and food chemistry September 1987 Volume 35, Issue 5 D pp 794–797 |
Bufo alvarius - a potent hallucinogen |
Entheogens and education potential |
Hallucinogens and redemption |
HPPD - flashbacks |
JPharmBioAn-41-3-872 |
Mining_Recepterome_Review_JBC |
Natural hallucinogens growing in USA |
Nichols - Hallucinogens |
Pharmañopo - Yopo pharmacology |
Pharmepena - epena pharmacology |
Proposed Mechanism for Dreams and Sleep |
Psychedelic adverse effects |
Psychointegrators multidisciplinary approach |
Psychopharmacology of hallucinogens |
Psychosis and hallucinogens consciousness model |
Reducing drug problems with set and setting |
Serotonin and hallucinogens |
Study of Values of psychedelic users |